CARDIAC & VASCULAR SURGERY DEVICES HUBCardiac & vascular surgery market analysis and updatesWith an ageing population and the rising prevalence of cardiovascular diseases, the demand for cardiac and vascular surgery is growing. Technologies being developed to treat patients more efficiently and less invasively using minimally invasive surgery (MIS) techniques and robotics are driving the shift from an open surgery approach to MIS or hybrid approaches in cardiovascular surgery.Clearstate offers market data, forecasts, and trend predictions to give you the insight to adjust your business strategy to meet the growing opportunities in cardiac and vascular surgery. Our cardiac & vascular surgery devices hub is regularly updated to share our findings on market developments and its strategy implications. Inquire now
Trends in minimally invasive cardiovascular surgery in JapanA new wave of minimally invasive surgery (MIS) adoption in Japan is emerging due to improved technology and the availability of reimbursement and surgical devices. Read more
2025: five trends in South-east Asia’s cardiovascular surgery and device marketGrowth is expected to be strong for South-east Asia’s (SEA) cardiovascular surgical device market. Increased affluence in the region is driving up both the prevalence of heart disease and care delivery standards. Read more
Key domestic market players shaping the future of TAVR in ChinaEmergent covid-19 screening technologies coupled with declining testing demand are likely to erode the molecular-based covid-19 test market in Asia-Pacific (APAC) over the next five years. Read more
TAVR bioprosthetic heart valve market to grow between 20-25% in east AsiaTranscatheter aortic valve replacements (TAVR) is set to be one of the fastest-growing procedural areas in cardiac surgery for Asia. Opportunities are growing particularly in east Asia as the number of TAVR candidates rises in an aging population, and with an expanding indication towards younger, lower-risk patients. Read more
TAVR Japan: a third of procedures carried out in small and mid-sized hospitalsTranscatheter aortic valve replacements (TAVR) is set to be Japan’s fastest-growing procedural areas in cardiac surgery. Opportunities are growing particularly as the number of TAVR candidates rises in an aging population, and with an expanding indication towards younger, lower-risk patients. Read more
Minimally invasive surgery: trends in cardiologyWith better surgery outcomes and shorter patient recovery times, minimally invasive surgery (MIS) techniques have been increasingly adopted in cardiology procedures such as heart valve replacement surgeries. Read more
report by clearstateThe future of TAVR in AsiaUnderstand the future of cardiac surgery in Asia, with our prescient insight into the cardiovascular surgery sector. Explore openings in the market as transcatheter aortic valve replacements (TAVR) will be one of the fastest-growing procedural areas in cardiac surgery for the region. The report examines Asia’s TAVR market landscape and the strategy implications that could enable improvements in TAVR access for the region. Learn more
Clearstate newsletterSign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts. Sign up now